# Chris Danek

> Founder & CEO of Bessel (helped 3 medtech startups to 9-figure exits)

Founder & CEO of Bessel, where he's helped medtech startups scale to 9-figure exits using the Build for Impact framework.

Former CEO & co-founder of AtheroMed, acquired by Volcano Corp (now Philips) after raising $17M and securing FDA/CE approvals.

Led R&D at Asthmatx, which developed the first FDA-approved interventional asthma therapy—acquired by Boston Scientific.

Held senior leadership roles in startups backed by VCs, strategics, and government funding; built teams that achieved first-in-human milestones in under 6 months.

Created frameworks that consistently reduce COGS, improve usability, and unlock capital-efficient growth in FDA-regulated innovation environments.

Lecturer and advisor at Santa Clara University, University of Texas El Paso, Tec de Monterey, and Catholic University.

Things I can advise on:
✔️ How to validate medtech ideas
✔️ Guidance on FDA/CE strategy
✔️ Tips on building development teams
✔️ Best practices for medtech development
✔️ AI in development teams 
✔️ Advice on securing medtech funding
✔️ Scale readiness: how to reduce COGS & increase quality
✔️ Strategy for medtech exits

Excited to help founders scale smarter and avoid costly missteps—especially in life-changing innovations.

## Offerings

- Video call (15 min): $175.00

## Example Questions

- I’m thinking of starting a company. What are the next few things I should focus on?
- How do I know if my business idea will work?
- How would you approach growth for my business?
- What key metrics should I aim for at different stages to be a best in class company?

## Links

- [Expert profile](/ChrisDanek)
- [Avatar](https://media.intro.co/avatars/1360332ZbH1Sj9t.jpg)
- [Marketplace](/marketplace)